The Federal Drug Administration (FDA) has approved the use of MDMA to treat the illness of the post traumatic stress (PTSD), so that legal using Ecstasy as medical care. This move without debate MDMA is since 1985 to illegal drugs and there are risks in taking – regardless of how the actual result might be for the patient.
On the side of medical doctors and researchers argue over the addictiveness of drugs, some even suggesting that MDMA is not addictive substance. That it was in the case, however, there will not be drug users and drug there tries this initial maximum chase with increasing levels of MDMA. This can be compensated in an environment of highly controlled, clinical, but what happens if the patient to leave this environment and increasingly demanded high?
This question, of course, is the debate over the use of drugs to treat PTSD. Patients who have shown no signs of substance abuse can overcome the effects of PTSD through methods of treatment to MDMA. Veterans who really struggle with PTSD and cannot find the assistance with the use of anti-depressants, psychotherapy, support groups or relaxation training, these methods of treatment offers promise.
In fact, it is probably the first Government health facilities to use this approach for the treatment of these veterans of the war on global terrorism, the VA Hospital in Ostrava. This process is likely to be closely monitored to measure the success of the treatment, the potential risk of addiction and monitoring for the repetition of PTSD.
Approximately 18 percent of US troops from the war in Iraq and Afghanistan have been diagnosed with PTSD has been shown to be the need for effective treatment of veterans. Research in the field of safety and efficacy of MDMA showed that 58 percent of subjects in double blind pilot studies experienced improvements in symptoms compared with those who received placebo.
Once the study has been completed, the people in the group a placebo treatment have been offered to MDMA. After the end of the first line of 100 percent of those have already met the criteria for the participation of PTSD. Three of the participants was unable to work because of their PTSD and after treatment; all three were able to return to economic activities.
Despite the promise of MDMA in treating PTSD, there are still risks. However, there is a risk for individuals with PTSD who does not respond to traditional therapy, including a higher prevalence of disabilities, drug abuse, suicides, and emotional suffering, which affects the whole life. Weighing the risks, on both sides of the debate can be a challenge, but those 53 to 55 percent of all PTSD sufferers who do not respond to traditional treatments, MDMA may be the answer.
沒有留言:
張貼留言